Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peter van Tintelen

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
European Heart Journal|January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and EuropeRichard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
European Heart Journal|September 17, 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variantsAlessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, et al.
European Heart Journal|July 16, 2024
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriersRichard T Carrick, Alessio Gasperetti, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
The Journal of Clinical Investigation|July 3, 2019
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyJason D Roberts, Nathaniel P Murphy, Robert M Hamilton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
American Journal of Human Genetics|May 23, 2025
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
European Heart Journal|January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and EuropeRichard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
European Heart Journal|September 17, 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variantsAlessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, et al.
European Heart Journal|July 16, 2024
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriersRichard T Carrick, Alessio Gasperetti, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
The Journal of Clinical Investigation|July 3, 2019
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyJason D Roberts, Nathaniel P Murphy, Robert M Hamilton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
American Journal of Human Genetics|May 23, 2025
Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Pageof 24